Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 2/20 | 0.42 |
| ▸ | ADORA3 | P0DMS8 | 9/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.39 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.39 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24600936 | 0.93 | ADORA3 (0.40) | NT5EADORA3ADORA2AADORA1ADORA2B | |
| SCHEMBL24600901 | 0.92 | ADORA2A (0.44) | NT5EADORA3ADORA2AADORA1KCNH2 | |
| SCHEMBL24600687 | 0.91 | ADORA3 (0.45) | NT5EADORA3ADORA2AADORA1KCNH2 | |
| SCHEMBL24600684 | 0.91 | NT5E (0.40) | NT5EADORA3ADORA2AADORA1KCNH2 | |
| SCHEMBL24600898 | 0.90 | KCNH2 (0.40) | NT5EADORA3ADORA2AADORA1KCNH2 | |
| SCHEMBL30850689 | 0.88 | ADORA3 (0.54) | NT5EADORA3ADORA2AADORA1ADORA2B | |
| SCHEMBL26628535 | 0.88 | ADORA3 (0.54) | NT5EADORA3ADORA2AADORA1ADORA2B | |
| SCHEMBL24601276 | 0.87 | KCNA5 (0.46) | NT5EADORA3ADORA2AADORA1KCNH2 | |
| SCHEMBL24601117 | 0.87 | ADORA3 (0.42) | NT5EADORA3ADORA2AADORA1ADORA2B | |
| SCHEMBL24600916 | 0.86 | KCNA5 (0.45) | NT5EADORA3ADORA2AADORA1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022143740-A1 | ADENOSINE A3 RECEPTOR AGONIST, PREPARATION METHOD THEREFOR, AND USE THEREOF | 浙江春禾医药科技有限公司 | 2022-07-07 | — | — | WO | disclosed |